BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 31679482)

  • 1. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
    Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV cascade of care among serodiscordant couples in four high HIV prevalence settings in sub-Saharan Africa.
    Chihana ML; Conan N; Ellman T; Poulet E; Garone DB; Ortuno R; Wanjala S; Masiku C; Etard JF; Davies MA; Maman D
    S Afr Med J; 2021 Aug; 111(8):768-776. PubMed ID: 35227358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaching the 'first 90': Gaps in coverage of HIV testing among people living with HIV in 16 African countries.
    Staveteig S; Croft TN; Kampa KT; Head SK
    PLoS One; 2017; 12(10):e0186316. PubMed ID: 29023510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
    Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
    J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cascade of HIV care and population viral suppression in a high-burden region of Kenya.
    Maman D; Zeh C; Mukui I; Kirubi B; Masson S; Opolo V; Szumilin E; Riche B; Etard JF
    AIDS; 2015 Jul; 29(12):1557-65. PubMed ID: 26244395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.
    Huerga H; Van Cutsem G; Ben Farhat J; Puren A; Bouhenia M; Wiesner L; Dlamini L; Maman D; Ellman T; Etard JF
    BMC Public Health; 2018 Mar; 18(1):303. PubMed ID: 29499668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with HIV status awareness and Linkage to Care following home based testing in rural Malawi.
    Maman D; Ben-Farhat J; Chilima B; Masiku C; Salumu L; Ford N; Mendiharat P; Szumilin E; Masson S; Etard JF
    Trop Med Int Health; 2016 Nov; 21(11):1442-1451. PubMed ID: 27714902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equity of antiretroviral treatment use in high HIV burden countries: Analyses of data from nationally-representative surveys in Kenya and South Africa.
    Moyo S; Young PW; Gouws E; Naidoo I; Wamicwe J; Mukui I; Marsh K; Igumbor EU; Kim AA; Rehle T
    PLoS One; 2018; 13(8):e0201899. PubMed ID: 30096199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closer to 90-90-90. The cascade of care after 10 years of ART scale-up in rural Malawi: a population study.
    Maman D; Chilima B; Masiku C; Ayouba A; Masson S; Szumilin E; Peeters M; Ford N; Heinzelmann A; Riche B; Etard JF
    J Int AIDS Soc; 2016; 19(1):20673. PubMed ID: 26894388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study.
    Ngongondo M; Rosenberg NE; Stanley CC; Lim R; Ongubo D; Broadhurst R; Speight C; Flick R; Tembo P; Hosseinpour MC
    BMC Infect Dis; 2018 Jan; 18(1):39. PubMed ID: 29334932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncommunicable Diseases Burden and Risk Factors in a Cohort of HIV+ Elderly Patients in Malawi.
    Ciccacci F; Tolno VT; Doro Altan AM; Liotta G; Orlando S; Mancinelli S; Palombi L; Marazzi MC
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1106-1111. PubMed ID: 31468993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
    May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
    Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced HIV disease at presentation to care in Nairobi, Kenya: late diagnosis or delayed linkage to care?--a cross-sectional study.
    van der Kop ML; Thabane L; Awiti PO; Muhula S; Kyomuhangi LB; Lester RT; Ekström AM
    BMC Infect Dis; 2016 Apr; 16():169. PubMed ID: 27091128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and factors associated with viral non-suppression in people living with HIV receiving antiretroviral therapy in sub-Saharan Africa: A systematic review and meta-analysis.
    Mosha IH; Nyondo GG; Munishi CG; Njiro BJ; Bwire GM
    Rev Med Virol; 2024 May; 34(3):e2540. PubMed ID: 38708846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial.
    Thomas R; Burger R; Harper A; Kanema S; Mwenge L; Vanqa N; Bell-Mandla N; Smith PC; Floyd S; Bock P; Ayles H; Beyers N; Donnell D; Fidler S; Hayes R; Hauck K;
    Lancet Glob Health; 2017 Nov; 5(11):e1133-e1141. PubMed ID: 28964756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa.
    Benzekri NA; Sambou JF; Ndong S; Tamba IT; Faye D; Diallo MB; Diatta JP; Faye K; Sall I; Sall F; Manga NM; Malomar JJ; Ndour CT; Hawes SE; Seydi M; Gottlieb GS
    BMC Infect Dis; 2019 Mar; 19(1):261. PubMed ID: 30876400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.